Description: Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; and Revanex, an acid pump antagonist for the treatment of peptic ulcers and gastritis-related mucosal injury. The company also provides ETC products, such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory and allergy, and neuro systems, as well as anti-infective, anti-cancer, and hormone and other products; and analgesics, anti-rheumatics, and anesthetics. In addition, it offers over-the-counter (OTC) products, including vitamins and minerals, hepatopathy drugs and tonics, respiratory system drugs, alimentary system drugs, dermatology and analgesics drugs, and others; and household and healthcare products, such as bleaches, detergents, pesticides, and oral care products. Further, the company engages in dental business and provides implants, dental equipment/consumable, and dental care products. Additionally, the company manufactures and sells medical supplies for livestock, aquatic animals, and companion animals; and provides contract manufacturing services. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.
Home Page: www.yuhan.co.kr
74, Noryangjin-ro
Seoul,
South Korea
Phone:
82 2 828 0181
Officers
| Name | Title |
|---|---|
| Mr. Wook-Je Cho | Pres, CEO & Exec. Director |
| Ms. Su Youn Nam M.D., Ph.D. | Sr. MD & Director of Central Research Institute |
| Mr. Jong-Hong Lee | Managing Director of Dental Bus. TFT |
| Mr. Chul-Ki Sa | MD & Chief of Devel. Unit |
| Mr. Duk-Hyun Kang | MD & GM of Living Health Department |
| Mr. Jung-Man Ha | Managing Director |
| Mr. Hyeon-Yun Shin | MD & GM of ETC Sales 5 Department |
| Mr. Bok-Kyu Yoon | MD & GM of ETC Bus. 8 Department |
| Mr. Eun-Shik Kim | Managing Director of Health Functional Food Bus. Tft |
| Mr. Jae-Kyo Kim | Exec. Vice Director & Head of the Pharmaceutical Bus. Mgnt. Dept. |
Exchange: KO
Country: KR
Currency: Korean Won (₩)
| Forward PE: | 30.303 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.0174 |
| Price-to-Sales TTM: | 2.2213 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |